Denali Therapeutics Inc. (DNLI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Denali Therapeutics Inc.

    NASDAQ: DNLI · Real-Time Price · USD
    13.43
    -0.05 (-0.37%)
    At close: Sep 25, 2025, 3:59 PM
    13.43
    0.00%
    After-hours: Sep 25, 2025, 04:20 PM EDT

    Denali Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 330.53M 108.46M 48.66M
    Cost of Revenue
    		 n/a 16.73M 7.03M 5.61M
    Gross Profit
    		 n/a 313.81M 101.43M 43.05M
    Operating Income
    		 -487.34M -196.7M -340.74M -295.75M
    Interest Income
    		 n/a 51.51M 14.77M 4.59M
    Pretax Income
    		 -422.7M -145.19M -325.97M -291.16M
    Net Income
    		 -422.77M -145.22M -325.99M -290.58M
    Selling & General & Admin
    		 105.44M 103.35M 90.47M 79.06M
    Research & Development
    		 396.44M 423.88M 358.73M 265.35M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 501.88M 527.23M 449.21M 344.41M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 527.23M 449.21M 344.41M
    Income Tax Expense
    		 68K 30K 21K -575K
    Shares Outstanding (Basic)
    		 164.47M 137.37M 125.53M 121.52M
    Shares Outstanding (Diluted)
    		 164.47M 137.37M 125.53M 121.52M
    EPS (Basic)
    		 -2.57 -1.06 -2.6 -2.39
    EPS (Diluted)
    		 -2.57 -1.06 -2.6 -2.39
    EBITDA
    		 -414.91M -179.97M -330.36M -287.16M
    EBIT
    		 -422.7M -196.7M -340.74M -295.75M
    Depreciation & Amortization
    		 7.79M 16.73M 7.03M 5.61M

    Add to Watchlist